TrialClinical pharmacology in drug development2026

Randomized Phase 1 Studies Evaluating the Safety, Tolerability, Pharmacokinetics, and Target Occupancy of Zampilimab in Healthy Participants.

Jo Collier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.